|
41 |
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Aliperta, Roberta. - London : Nature Publishing Group, 2017
|
|
|
42 |
Overcoming Instability of Antibody‐Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
Enthalten in Advanced healthcare materials Bd. 5, 2016, Nr. 16: 2055-2068. 14 S.
|
|
|
|
43 |
Targeted Nanomaterials: Overcoming Instability of Antibody‐Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies (Adv. Healthcare Mater. 16/2016)
Enthalten in Advanced healthcare materials Bd. 5, 2016, Nr. 16: 1994-1994. 1 S.
|
|
|
|
44 |
Multiformat T‐Cell‐Engaging Bispecific Antibodies Targeting Human Breast Cancers †
Enthalten in Angewandte Chemie Bd. 127, 2015, Nr. 24: 7128-7133. 6 S.
|
|
|
|
45 |
Multiformat T‐Cell‐Engaging Bispecific Antibodies Targeting Human Breast Cancers †
Enthalten in Angewandte Chemie / International edition Bd. 54, 2015, Nr. 24: 7022-7027. 6 S.
|
|
|
|
46 |
Bispecific, diagnostic antibodies for enhanced detection of dimerized or phosphorylated oncoproteins
Enthalten in Science-Business eXchange Bd. 7, Nr. 11, date:3.2014: 326
|
|
|
|
47 |
Escherichia coli coculture for making bispecific antibodies
Enthalten in Science-Business eXchange Bd. 6, Nr. 30, date:8.2013: 807
|
|
|
|
48 |
Controlled Fab-arm exchange (cFAE) approach to develop bispecific antibodies for therapeutic use
Enthalten in Science-Business eXchange Bd. 6, Nr. 11, date:3.2013: 275
|
|
|
|
49 |
Current strategies in antibody engineering: Fc engineering and pH‐dependent antigen binding, bispecific antibodies and antibody drug conjugates
Enthalten in Biotechnology journal Bd. 7, 2012, Nr. 12: 1444-1450. 7 S.
|
|
|
|
50 |
Chemically modified bispecific antibodies
Enthalten in Science-Business eXchange Bd. 5, Nr. 30, date:8.2012: 796
|
|
Administration
